(Q48656570)

13 February 2018

title

Evidence for CCK(A) receptor involvement in the acquisition of conditioned activity produced by cocaine in rats. (English)

1 reference

13 February 2018

1

S A Josselyn

1 reference

13 February 2018

author name string

A De Cristofaro

series ordinal

2

1 reference

13 February 2018

F J Vaccarino

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

13 February 2018

published in

Brain Research

1 reference

13 February 2018

volume

763

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

93-102

1 reference

13 February 2018

Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Role of D-1 and D-2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Distribution of cholecystokinin-like peptides in the human-brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Interaction of CCKB receptors with amphetamine in responding for conditioned rewards.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCKA receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

PD-135158, a CCKB receptor antagonist, microinjected into the nucleus accumbens and the expression of conditioned rewarded behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Environment-specific conditioning and sensitization with (+)-amphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Failure of cholecystokinin antagonists to modify the discriminative stimulus effects of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

New peptide in the vertebrate CNS reacting with antigastrin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900410-1

10.1016/S0006-8993(97)00410-1

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

release_35vcefraz5ce7dhktr4rc7tb6u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/35vcefraz5ce7dhktr4rc7tb6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9272833

1 reference

13 February 2018